Skip to content

Generate Biomedicines, Inc. GENB Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Lockheed Martin logo
Lockheed MartinLMT
$6.93B-19.0%
CHE
ChemedCHE
$9.9M+22.2%
UL Solutions logo
UL SolutionsULS
$93M-24.4%
Fidelity National Information Services logo
Fidelity National Information ServicesFIS
$7.04B+50.0%
Popular logo
PopularBPOP
$193.97M+21.9%
Hubbell logo
HubbellHUBB
$9.7M+54.0%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's software and technology licenses, net?
Generate Biomedicines, Inc. (GENB) reported software and technology licenses, net of $4.75M in Q1 2026.